Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Gaku Miyamura, Hiroki Wakabayashi, Nobuto Nagao, Sho Kato, Taro Nakagawa, Yohei Naito & Akihiro Sudo. (2021) Prevention of bone loss and improvement of pain-related behavior in hind limb-unloaded mice by administration of teriparatide and bisphosphonate. Modern Rheumatology 31:3, pages 733-742.
Read now
Read now
Teresa Paolucci & Vincenzo Maria Saraceni. (2016) Management of chronic pain in osteoporosis: challenges and solutions. Journal of Pain Research 9, pages 177-186.
Read now
Read now
Satoshi Soen, Saeko Fujiwara, Ryoichi Takayanagi, Masayo Sato, Mika Tsujimoto, Takanori Yamamoto, Hiroyuki Enomoto & John H. Krege. (2015) Japan Fracture Observational Study (JFOS): patient characteristics and interim data on the use of daily teriparatide in Japanese patients with osteoporosis. Current Medical Research and Opinion 31:9, pages 1771-1779.
Read now
Read now
Ö. Ljunggren, C. L. Benhamou, J. Dekker, G. Kapetanos, T. Kocjan, B. L. Langdahl, N. Napoli, H. Petto, T. Nikolić & E. Lindh. (2014) Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS). Current Medical Research and Opinion 30:8, pages 1607-1616.
Read now
Read now
Steven Boonen, Koen Milisen, Evelien Gielen & Dirk Vanderschueren. (2011) Sequential therapy in the treatment of osteoporosis. Current Medical Research and Opinion 27:6, pages 1149-1155.
Read now
Read now
Sophia Ish-Shalom, Constantin Dumitrache, Timour Fikry El-Husseini, Azza Hussein, Clare Barker & Imre Pavo. (2011) Postmenopausal women with osteoporosis: experience when treated with teriparatide in clinical practice. Current Medical Research and Opinion 27:2, pages 343-353.
Read now
Read now
Articles from other publishers (27)
Marie‐Eva Pickering, Rose‐Marie Javier, Sandrine Malochet, Gisele Pickering & Jules Desmeules. (2023) Osteoporosis treatment and pain relief: A scoping review. European Journal of Pain 28:1, pages 3-20.
Crossref
Crossref
Cristina Dettori, Francesca Ronca, Marco Scalese & Federica Saponaro. (2023) Parathyroid Hormone (PTH)-Related Peptides Family: An Intriguing Role in the Central Nervous System. Journal of Personalized Medicine 13:5, pages 714.
Crossref
Crossref
Somayyeh Ebrahimi, Alireza Navabazam, Fateme Salemi, Fatemeh Khaleghi, Mohsen Barzegar, Fatemeh Saghafi & Hossien Fallahzadeh. (2023) The efficacy of teriparatide (Cinnopar®) on bone repair in mandibular fractures: A single blinded randomized clinical trial. Journal of Cranio-Maxillofacial Surgery.
Crossref
Crossref
Neharika Bhadouria, Alycia G. Berman, Joseph M. Wallace & Nilsson Holguin. (2022) Raloxifene Stimulates Estrogen Signaling to Protect Against Age- and Sex-Related Intervertebral Disc Degeneration in Mice. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Tomoya Tanaka, Ryoko Takao-Kawabata, Aya Takakura, Yukari Shimazu, Momoko Nakatsugawa, Akitoshi Ito, Ji-Won Lee, Koh Kawasaki & Tadahiro Iimura. (2020) Teriparatide relieves ovariectomy-induced hyperalgesia in rats, suggesting the involvement of functional regulation in primary sensory neurons by PTH-mediated signaling. Scientific Reports 10:1.
Crossref
Crossref
Sho Kato, Hiroki Wakabayashi, Taro Nakagawa, Gaku Miyamura, Yohei Naito, Takahiro Iino & Akihiro Sudo. (2019) Teriparatide improves pain-related behavior and prevents bone loss in ovariectomized mice. Journal of Orthopaedic Surgery 28:1, pages 230949901989319.
Crossref
Crossref
Chengzhi Yang, Guoping Le, Changwei Lu, Renjie Wei, Wanjie Lan, Jingli Tang & Xinli Zhan. (2020) Effects of teriparatide compared with risedronate in the treatment of osteoporosis. Medicine 99:7, pages e19042.
Crossref
Crossref
Peter G. Passias, Rivka C. Ihejirika-Lomedico, Hesham Saleh, Max Egers, Avery E. Brown, Haddy Alas, Katherine E. Pierce, Cole Bortz & Yael Ihejirika. 2020. Vertebral Compression Fractures in Osteoporotic and Pathologic Bone. Vertebral Compression Fractures in Osteoporotic and Pathologic Bone
183
189
.
Fumitoshi Omura. (2019) Impact of patient background factors on the treatment efficacy of once-weekly teriparatide. Osteoporosis and Sarcopenia 5:2, pages 51-56.
Crossref
Crossref
Seok-Ha HwangYoung-Kyun WooHo-Seung JeonSeung-Pyo Suh, Joo-Young KimJae-Nam Kim. (2019) Treatment Effect with Weekly Teriparatide in the Vertebral Compression Fractures in Patients with Severe Osteoporosis. Journal of the Korean Orthopaedic Association 54:6, pages 528.
Crossref
Crossref
Nicola Napoli, Bente. L. Langdahl, Östen Ljunggren, Eric Lespessailles, George Kapetanos, Tomaz Kocjan, Tatjana Nikolic, Pia Eiken, Helmut Petto, Thomas Moll, Erik Lindh & Fernando Marin. (2018) Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS). Calcified Tissue International 103:4, pages 359-371.
Crossref
Crossref
Takayuki Dohke, Kousuke Iba, Megumi Hanaka, Kumiko Kanaya, Shunichiro Okazaki & Toshihiko Yamashita. (2017) Teriparatide rapidly improves pain-like behavior in ovariectomized mice in association with the downregulation of inflammatory cytokine expression. Journal of Bone and Mineral Metabolism 36:5, pages 499-507.
Crossref
Crossref
Bente L. Langdahl, Östen Ljunggren, Claude-Laurent Benhamou, Fernando Marin, George Kapetanos, Tomaz Kocjan, Eric Lespessailles, Nicola Napoli, Tatjana Nikolic, Helmut Petto, Thomas Moll & Erik Lindh. (2016) Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS). Calcified Tissue International 99:3, pages 259-271.
Crossref
Crossref
Charlotte Ørsted Frost, Rikke Rie Hansen & Anne-Marie Heegaard. (2016) Bone pain: current and future treatments. Current Opinion in Pharmacology 28, pages 31-37.
Crossref
Crossref
Kousuke Iba, Takayuki Dohke, Megumi Hanaka, Kumiko Kanaya, Yasuhisa Abe & Toshihiko Yamashita. (2016) <b>Skeletal pain induced by regional osteoporosis </b>. PAIN RESEARCH 31:4, pages 203-209.
Crossref
Crossref
Hiroyuki Tsuchie, Naohisa Miyakoshi, Yuji Kasukawa, Tomio Nishi, Hidekazu Abe, Toyohito Segawa & Yoichi Shimada. (2015) The effect of teriparatide to alleviate pain and to prevent vertebral collapse after fresh osteoporotic vertebral fracture. Journal of Bone and Mineral Metabolism 34:1, pages 86-91.
Crossref
Crossref
Erik Fink Eriksen. 2016. The Duration and Safety of Osteoporosis Treatment. The Duration and Safety of Osteoporosis Treatment
37
59
.
T Songpatanasilp, M Mumtaz, H Chhabra, M Yu & S Sorsaburu. (2014) Back pain in patients with severe osteoporosis on teriparatide or antiresorptives: a prospective observational study in a multiethnic population. Singapore Medical Journal 55:09, pages 493-501.
Crossref
Crossref
M. Sosa Henríquez & M.J. Gómez de Tejada Romero. (2014) Tratamiento de la osteoporosis. Medicine - Programa de Formación Médica Continuada Acreditado 11:60, pages 3545-3554.
Crossref
Crossref
Östen Ljunggren, Annabel Barrett, Ivaylo Stoykov, Bente L Langdahl, Willem F Lems, J Bernard Walsh, Astrid Fahrleitner-Pammer, Gerald Rajzbaum, Franz Jakob, Dimitrios Karras & Fernando Marin. (2013) Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study. BMC Musculoskeletal Disorders 14:1.
Crossref
Crossref
Erik Fink Eriksen. 2013. Osteoporosis. Osteoporosis
158
177
.
P. Hadji, J. R. Zanchetta, L. Russo, C. P. Recknor, K. G. Saag, F. E. McKiernan, S. L. Silverman, J. Alam, R. T. Burge, J. H. Krege, M. C. Lakshmanan, D. N. Masica, B. H. Mitlak & J. L. Stock. (2011) The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures. Osteoporosis International 23:8, pages 2141-2150.
Crossref
Crossref
Ming-Huei Cheng, Jung-Fu Chen, Jong-Ling Fuh, Wen-Ling Lee & Peng-Hui Wang. (2012) Osteoporosis treatment in postmenopausal women with pre-existing fracture. Taiwanese Journal of Obstetrics and Gynecology 51:2, pages 153-166.
Crossref
Crossref
F Jakob, H Oertel, B Langdahl, O Ljunggren, A Barrett, D Karras, J B Walsh, A Fahrleitner-Pammer, G Rajzbaum, C Barker, W F Lems & F Marin. (2012) Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study. European Journal of Endocrinology 166:1, pages 87-97.
Crossref
Crossref
Marius E. Kraenzlin & Christian Meier. (2011) Parathyroid hormone analogues in the treatment of osteoporosis. Nature Reviews Endocrinology 7:11, pages 647-656.
Crossref
Crossref
Stuart L. Silverman & Keaton Nasser. (2011) Teriparitide Update. Rheumatic Disease Clinics of North America 37:3, pages 471-477.
Crossref
Crossref
K. Aloumanis, D. Karras, V. Drossinos, E. Korelis & A. Polydorakis. (2011) Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo Observational Study. Journal of Osteoporosis 2011, pages 1-8.
Crossref
Crossref